SN

Simran Nahata

Active Director Director DIN 09379293
DIN 09379293 First appointment Oct 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2021
Shareholding value •••• Premium profile

About Simran Nahata

Data last updated:

Simran Nahata is a Director at Truly Health Private Limited (since 2021). The company operates in Chemicals. Truly Health Private Limited reported revenue of ₹46.3 Lakh (FY 2025).

DIN 09379293
Primary Designation Director
Industry Chemicals
First Appointment 28 Oct 2021
Oldest Company Age 5 yrs
Largest company Truly Health Private Limited · ₹46.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Truly Health Private Limited U24290MH2021PTC370461
Director28 Oct 20212021₹46.3 Lakh (FY 2025)Active

Board colleagues of Simran Nahata

NameDINCompanyDesignation
Roop Chand Jain08444848Truly Health Private LimitedDirector

Directorship timeline

Open interactive timeline →
Truly Health Private Limited
Premium access

Shareholding and investment profile for Simran Nahata

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Simran Nahata

Simran Nahata currently holds 1 directorship: Truly Health Private Limited (Director, since 28 Oct 2021, revenue ₹46.3 Lakh (FY 2025)).

Simran Nahata was first appointed on 28 Oct 2021 as Director at Truly Health Private Limited.

The current boards of Simran Nahata's companies include Roop Chand Jain (Truly Health Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available